ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis

ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from using federal funds to investigate medical marijuana cases within states that have legalized medical marijuana.

Senator Cory Booker Tries to Legalize Marijuana Nationally

Earlier this week, Sen. Cory Booker (D-NJ) introduced legislation that would begin to end the unfair prohibition of marijuana throughout the federal government. The bill would also serve to repair the damage done to the country via prohibition.

Booker was quoted stating that “I believe the federal government should get out of the illegal marijuana business. You see what’s happening around this country right now. Eight states and the District of Columbia have moved to legalize marijuana.

ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis

ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from using federal funds to investigate medical marijuana cases within states that have legalized medical marijuana.

Senate Passes Marijuana Amendment While Trump and Sessions Try to Stop It

With Marijuana state laws threatened, a new amendment could potentially help to give states the rights they deserve. Occurring on July 27th, Senator Patrick Leahy (D-VT) went to the Senate and successfully proposed and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee which will protect lawful medical marijuana programs from being impeded upon by the Dept. of Justice.

ChineseInvestors.com (CIIX) Eyes Expansion in CBD Markets throughout North America

  • Sees opportunities in the fast-growing international medical marijuana market
  • Plans store opening in San Gabriel, California, with online hemp-based product store already in Shanghai, China, targeting the global Chinese-speaking community
  • Consilium Global Research projects that company revenues will reach $14.8 million by FY2020

The strategic approach of ABcann’s growth technique

In this interview, Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public, the factors that differentiate the company from competitors, as well as their strategy in the Canadian marketplace. Aaron discusses how the company manages the health of its plants in order to ensure that deviation and variance in the product is minimal. He goes on to explain how the company’s path to success in Canada is based on a scaling method, which allows the company to grow one premium product with an increased production capacity.